Larvol Delta - FDA-Grants-Fast-Track-Designation-to-CNS-Pharmaceuticals-for-Berubicin-for-the-Treatment-of-Recurrent-Glioblastoma-Multiforme

berubicin (RTA 744) - CNS Pharma, WPD Pharma

https://www.prnewswire.com/news-releases/fda-grants-fast-track-designation-to-cns-pharmaceuticals-for-berubicin-for-the-treatment-of-recurrent-glioblastoma-multiforme-301321481.html

Jun 29, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next